A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

Clinical trial NCT06759649 · RECRUITING

Trial details

NCT number: NCT06759649
Sponsor: Compugen Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Cancer, Malignant Tumors

Start date: 2025-01-07
Primary completion: 2027-11-22
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.